Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: Frequent long-term microchimerism in severe trauma patients

Blood

Volumn 93, Issue 9, 1999, Pages 3127-3139

  Lee, Tzong Hae ^b   Paglieroni, Teresa ^b   Ohto, Hitoshi ^b   Holland, Paul V ^b   Busch, Michael P ^a  

^a Blood Centers of the Pacific   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD15 ANTIGEN; CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BLOOD TRANSFUSION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HLA TYPING; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MALE; MICROCHIMERISM; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033134802     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.9.3127.409a40_3127_3139     Document Type: Article

References (66)

1. Lane TA, Anderson KC, Goodnough LT, Kurtz S, Moroff G, Pisciotto PT, Sayers M, Silberstein LE: Leukocyte reduction in blood component therapy. Ann Intern Med 117:151, 1992
2. Claas FHJ, Smeenk RTJ, Schmidt R, van Steenbrugge GJ, Eernisse JG: Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension. Exp Hematol 9:84, 1981
3. Murphy MF, Metcalfe P, Thomas H, Eve J, Ord J, Lister TA, Waters AH: Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimunization. Br J Haematol 62:529, 1986
4. Sniecinski I, O'Donnell MR, Nowicki B, Hill LR: Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood 71:1402, 1988
5. Schiffer CA: Prevention of alloimmunization against platelets (editorial). Blood 77:1, 1991
6. Nemo GJ, McCurdy PJ: Prevention of platelet alloimmunization (editorial). Transfusion 31:584, 1991
7. Holland PV: Prevention of transfusion-associated graft-vs-host disease (editorial). Arch Pathol Lab Med 113:285, 1989
8. Ferrara JLM, Deeg HJ: Graft-versus-host disease (review). N Engl J Med 324:667, 1991
9. McMilin KD, Johnson RL: HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease. Transfusion Med Rev 7:37, 1993
10. Shivdasani RA, Haluska FG, Dock NL, Dover JS, Kineke EJ, Anderson KC: Graft-vs-host disease associated with transfusion of blood from unrelated HLA-homozygous donors (brief report). N Engl J Med 328:766, 1993
11. Rawal BD, Davis RE, Busch MP, Vyas GN: Dual reduction in the immunologic and infectious complications of transfusion by filtration/ removal of leukocytes from donor blood soon after collection. Transfusion Med Rev 4:36, 1990 (suppl 1)
12. Busch MP, Lee T-H, Heitman J: Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent HIV-1 Infection: Implications for transfusion support of infected patients. Blood 80:2128, 1992
13. Opelz G, Sengar DPS, Mickey MR, Terasaki PI: Effect of blood transfusion on subsequent kidney transplants. Transplant Proc 5:253, 1973
14. Burrows L, Tartter P: Effect of blood transfusion on colonic malignancy recurrence rate. Lancet 2:662, 1982
15. Tartter PI, Quintero S, Barron DM: Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg 152:479, 1986
16. Comenzo RL, Berkman EM: Hematopoietic stem and progenitor cells from blood: Emerging uses for new components for transfusion (review). Transfusion 35:335, 1995
17. Vamvakas EC, Pineda AA: Determinants of the efficacy of prophylactic granulocyte transfusions: A meta-analysis. J Clin Apheresis 12:74, 1997
18. Stephan RN, Kisala JM, Dean RE, Geha AS, Chaudry IH: Effect of blood transfusion on antigen presentation function and on interleukin 2 generation. Arch Surg 123:235, 1988
19. Lazda VA, Pollak R, Mozes MF, Barber PL, Jonasson O: Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man. Transplantation 49:1084, 1990
20. Hamashima T, Yoshimura N, Matsui S, Lee CJ, Ohsaka Y, Oka T: The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat. Transplantation 49:171, 1990
21. Katsumori T, Yamaguchi Y, Mori K, Makino Y, Misumi M, Takata N, Goto M, Kikuchi N, Ogawa M: The time course of cell-mediated lympholysis in rat hepatic allograft recipients pretreated with a single donor-specific blood transfusion. Transplantation 54:531, 1992
22. Nakafusa Y, Terasaka R, Matsuo K, Konomi K, Flye MW: Advantages of donor-specific blood transfusion in the rat via the portal vein for renal transplantation. Am J Kidney Dis 21:433, 1993
23. Bayle F, Masson D, Zaoui P, Vialtel P, Janbon B, Bensa J-C, Cordonnier DJ: Beneficial effect of one HLA haplo- or semi-identical transfusion versus three untyped blood units on alloimmunization and acute rejection episodes in first renal allograft recipients. Transplantation 59:719, 1995
24. Lee T-H, Donegan EA, Slichter S, Busch MP: Transient increase in circulating donor leukocytes following allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. Blood 85:1207, 1995
25. Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, Foster JW, Frischauf A-M, Lovell-Badge R, Goodfellow PN: A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346:240, 1990
26. Vaughan RW, Lanchbury JSS, Marsh SGE, Hall MA, Bodmer JG, Welsh KI: The application of oligonucleotide probes to HLAclass II typing of the DRB sub-region. Tissue Antigens 36:149, 1990
27. Lee T-H, Stromberg RR, Heitman J, Tran K, Busch MP: Quantitation of residual white cells in filtered blood components by polymerase chain reaction amplification of HLA DQ-A DNA. Transfusion 34:986, 1994
28. Lee T-H, Sakahara NS, Fiebig EW, Hirschkorn DF, Johnson DK, Busch MP, for the Viral Activation Transfusion Study: Quantitation of white cell subpopulations by polymerase chain reaction using frozen whole-blood samples. Transfusion 38:262, 1998
29. Schechter GP, Soehnlen F, McFarland W: Lymphocyte response to blood transfusion in man. N Engl J Med 287:1169, 1972
30. Abbas AK, Lichtman AH, Pober JS: Cellular and Molecular Immunology (ed 2). Philadelphia, PA, Saunders, 1994, p 339
31. Korbling M, Fliedner TM: History of blood stem cell transplants, in Gale RP, Juttner CA, Henon P (eds): Blood Stem Cell Transplants. Cambridge, UK, Cambridge University Press, 1994, p 9
32. Starzl TE, Demetris AJ, Trucco M, Zeevi A, Ramos H, Terasaki P, Rudert WA, Kocova M, Ricordi C, Ildstad S, Murase N: Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 55:1272, 1993
33. Suberbielle C, Caillat-Zucman S, Legendre C, Bodemer C, Noel L-H, Kreis H, Bach J-F: Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. Lancet 343:1468, 1994
34. Schlitt HJ, Hundreiser J, Hisanaga M, Uthoff K, Karck M, Wahlers T, Wonigeit K, Pichlmayr R: Patterns of donor-type microchimerism after heart transplantation. Lancet 343:1469, 1994
35. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DiMaria MA: Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 93:705, 1996
36. Wenk RE, Chiafari FA: DNA typing of recipient blood after massive transfusion. Transfusion 37:1108, 1997
37. Svoboda P, Kantorova I, Ochmann J: Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma 36:336, 1994
38. Hauser CJ, Lagoo S, Lagoo A, Hale E, Hardy KJ, Barber WH, Bass JD, Poole GV: Human peripheral mononuclear cells do not show proinflammatory patterns of cytokine transcription in early trauma: A preliminary report. Shock 4:247, 1995
39. Grzelak I, Olszewski WL, Zaleska M, Durlik M, Lagiewska B, Muszynski M, Rowinski W: Blood cytokine levels rise even after minor surgical trauma. J Clin Immunol 16:159, 1996
40. Fisher E, Lennard V, Siefert P, Kluge A, Johannsen R: Blood transfusion-induced suppression of cellular immunity in man. Human Immunol 3:187, 1980
41. Klatzmann D, Gluckman JC, Foucault C, Duboust A, Bensussan A, Assogoba J, Berthelot JM: Modification of mixed lymphocyte reactivity after blood transfusions in man. Transplant Proc 15:1016, 1983
42. Stephan RN, Kisala JM, Dean RE, Geha AS, Chaudry IH: Effects of blood transfusion on antigen presentation function and on interleukin-2 generation. Arch Surg 123:235, 1988
43. Kalechman Y, Gafter U, Sobelman D, Sredni B: The effect of a single whole blood transfusion on cytokine secretion. J Clin Immunol 10:99, 1990
44. Roy R, Lachance JG, Beaudoin R: Prostaglandin-dependent suppressor factor induced following 1-5 blood transfusions: Role in kidney outcome. 1st International Symposium on Relevant Immunological Factors in Clinical Kidney Transplants. Heidelburg Transplant Proc 17:2383, 1985
45. Tartter PI: The effects of surgery and blood transfusions on immune function, in Tartter PI (ed): Immunologic Aspects of Blood Transfusion. Austin, TX, Landes, 1992
46. Stephan RN, Conrad PJ, Janeway CA, Geha AS, Baue AE, Chaudry IH: Decreased interleukin-2 production following simple hemorrhage. Surg Forum 37:75, 1986
47. Abraham E, Chang YH: Haemorrhage-induced alterations in function and cytokine production of T cells and T cell subpopulations. Clin Exper Immunol 90:497, 1992
48. Ayala A, Meldrum DR, Perrin MM, Chaudry IH: The release of transforming growth factor-beta following haemorrhage: Its role as a mediator of host immunosuppression. Immunology 79:479, 1993
49. Stephan RN, Kupper TS, Geha AS, Baue AE, Chaudry IH: Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg 122:62, 1987
50. Ayala A, Perrin MM, Chaudry IH: Defective macrophage antigen presentation following haemorrhage is associated with the loss of MHC class II (Ia) antigens. Immunology 70:33, 1990
51. Abraham F, Freitas AA: Hemorrhage produces abnormalities in lymphocyte function and lymphokine generation. J Immunol 142:899, 1989
52. Abraham E, Freitas AA, Coutinho AA: Hemorrhage in mice produces alterations in B cell repertoires. Cell Immunol 122:208, 1989
53. Cheadle WG, Pemberton RM, Robinson D, Livingston DH, Rodriguez JL, Polk HC Jr: Lymphocyte subset responses to trauma and sepsis. J Trauma 35:844, 1993
54. McCarter MD, Mack VE, Daly JM, Naama HA, Calvano SE: Trauma-induced alterations in macrophage function. Surgery 123:96, 1998
55. Giannoudis PV, Smith RM, Banks RE, Windsor AC, Dickson RA, Guillou PJ: Stimulation of inflammatory markers after blunt trauma. Br J Surg 85:986, 1998
56. Puyana JC, Pellegrini JD, De AK, Kodys K, Silva WE, Miller CL. Both T-helper-1- and T-helper-2-type lymphokines are depressed in posttrauma anergy (discussion 1045). J Trauma 44:1037, 1998
57. Lyons A, Kelly JL, Rodrick ML, Mannick JA, Lederer JA: Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection (discussion 458). Ann Surg 226:450, 1997
58. Grzelak I, Olszewski WL, Zaleska M, Ziolkowska A, Durlik M, Lagiewska B, Muszynski M, Rowinski W: Surgical trauma evokes a rise in the frequency of hematopoietic progenitor cells and cytokine levels in blood circulation. Eur Surg Res 30:198, 1998
59. Zellweger R, Ayala A, DeMaso CM, Chaudry IH: Trauma-hemorrhage causes prolonged depression in cellular immunity. Shock 4:149, 1995
60. Xu YX, Ayala A, Chaudry IH: Prolonged immunodepression after trauma and hemorrhagic shock. J Trauma 44:335, 1998
61. Aguilar MM, Battistella FD, Owings JT, Olson SA, MacColl K: Posttraumatic lymphocyte response: A comparison between peripheral blood T cells and tissue T cells. J Trauma 45:14, 1998
62. Harada M, Matsue K, Mori T, Ishino C, Kodo H, Hattori K: Viability of lymphocytes in stored blood: their surface markers, mitogenic response and MLC reactivity. Acta Haematol Jpn 42:30, 1979
63. Fiebig EW, Hirschkorn DF, Busch MP, Maino VC, and the Viral Activation Study: Proliferative potential of donor CD3+ T cells in cold stored whole blood (WB) and packed red cells measured by inducibility of CD69 expression. Blood 88:529a, 1996 (abstr 2103, suppl 1)
64. Ridge JP, Fuchs EJ, Matzinger P: Neonatal tolerance revisited: Turning on newborn T cells with dendritic cells. Science 271:1723, 1996
65. Fuchs EJ, Matzinger P: Is cancer dangerous to the immune system? Semin Immunol 8:271, 1996
66. Bonney EA, Matzinger P: The maternal immune system's interaction with circulating fetal cells. J Immunol 158:40, 1997